Island Pharmaceuticals: Developing a new drug for a disease that 400m people are diagnosed with a year – now that’s scalable!

Listen to ASX-listed Island Pharmaceuticals Managing Director Dr David Foster talk to Matt Birney on the Bulls N’ Bears Report about Island Pharmaceuticals’ remarkable redevelopment of a drug that was once created to tackle an entirely different disease. 

Island Pharmaceuticals: Developing a new drug for a disease that 400m people are diagnosed with a year – now that’s scalable!
Listen to ASX-listed Island Pharmaceuticals Managing Director Dr David Foster talk to Matt Birney on the Bulls N’ Bears Report about Island Pharmaceuticals’ remarkable redevelopment of a drug that was once created to tackle an entirely different disease.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement